Tandospirone augments cisplatin treatment by lowering cholesterol and managing distress in NSCLC patients - Quiz - MDSpire

Tandospirone augments cisplatin treatment by lowering cholesterol and managing distress in NSCLC patients

  • By

  • Xichun Qin

  • Bo Cheng

  • Shangshang Ma

  • Kun Li

  • Yongfei Fan

  • Mingjun Li

  • Rangrang Wang

  • Xuefeng Ai

  • Leilei Wu

  • Xiucheng Liu

  • Xiaojin Wu

  • Dong Xie

  • November 17, 2025

  • 0 min

Share

Original Source(s)

Tandospirone augments cisplatin treatment by lowering cholesterol and managing distress in NSCLC patients

  • by Xichun Qin, Bo Cheng, Shangshang Ma, Kun Li, Yongfei Fan, Mingjun Li, Rangrang Wang, Xuefeng Ai, Leilei Wu, Xiucheng Liu, Xiaojin Wu, Dong Xie

  • November 17, 2025

Related Content

Real-World Outcomes of Immune Checkpoint Inhibitors in Lung Cancer: A Study from a Middle-Income Nation

Worldwide Impact of Respiratory Cancers in 2022 and Projections for 2050: Incidence and Mortality Data from GLOBOCAN

CoreFormer high fidelity pulmonary nodule segmentation with structural core priors and geodesic implicit fields